Xxxx Xxxxx and Xx. Xx Xxxxxxxxx and the independent non-executive Directors of the Company are Mr. Xx Xxxxxxx, Xx. Xx Xxx and Xx. Xxx Xxxxxx.
Xxxx Xxxxx and Xx. Xxxxxx X LIANG as executive Directors; Dr.
Xxxx Xxxxx and Xx. Xxxxx Xxx-Xxxxx; and the independent non-executive Directors are Xx. Xxx Xxxxxx, Xx. Xxxxx Xxxx-Xxx, Xx. Xxx Xxxx Xxxx, Mr. Xxx Xxxx-Chiang and Mrs. Kong Xx Xxx Xxxx, Xxxxxx.
Xxxx Xxxxx and Xx. Xxxx Xxx Xxx as executive directors; Mr. Xxx Xx as non-executive director; Xx. Xxx Xxxx, Xx. Xxxx Xxxxxx and Xx. Xxxx Xxx Xxxx as independent non-executive directors.
Xxxx Xxxxx and Xx. XXXXX Xxx-Xxxxx; and the independent non-executive Directors are Mr. TOH Xxxxx Xx Xxxx, Xx. XXX Xxxxxx, Xx. XXXXX Xxx-Guey, Xx. XXX Xxxxx-Chou and Dr. XXX Xxxx-Bin.
Xxxx Xxxxx and Xx. Xxx Xxxxxxx; five are non-executive directors, namely Xx. Xxxx Xxxxxxxx (Chairman), Xx. Xxxx Xxxx, Xx. Xxxxx Xxxxxxxx, Xx. Xx Xxxxx and Xx. Xxxx Xxxxxxxxx; and three are independent non-executive directors, namely Xx. Xxx Xxxxxx, Xx. Xxxx Xxx Dune and Xx. Xxxx Xxxxx Xxxx, Xxxxxxx.
Xxxx Xxxxx and Xx. Xx Xxxxxxxxx are the Executive Directors; and Xx. Xxx Gen Xxxxxx, Xx. Xxx Xxxxxxx, Mr. Xxxxx Xxxx, Mr. Xxxx Xxxxxx and Xx. Xxxx Xxx Xxxxxx are the Independent Non-Executive Directors.
Xxxx Xxxxx and Xx. Xxxx Xxxxxxxx; and the independent non-executive directors of the Company are Xx.
Xxxx Xxxxx and Xx. Xxxxxxxx Xxxxxx by electronic mail to xxxxx.xxxxx@xxxxxxx.xxx and xxxxxxxx.xxxxxx@xxxxxxx.xxx (each a "Recipient"). The Recipient acting as an authorised receiving agent (Empfangsbote) will forward all received signature pages to all Parties by one of the means of communication referred to in Clause 22.22 (Counterparts and Conclusion of this Agreement) above. The Agreement shall be concluded as soon as all Parties to this Agreement as of the date hereof have received signature pages of all other Parties (actually or in a form acknowledged by German case law - Zugang). Promptly after receipt of all signature pages by the Parties, each party to this Agreement shall confirm such receipt. 22.4 For the purposes of Clause 22.3 (Counterparts and Conclusion of this Agreement) above, each Party authorises each Recipient by (counter)signing this Agreement to receive on its behalf the signature page(s) from all other Parties as an authorised receiving agent (Empfangsbote). For the avoidance of doubt, no Recipient shall have further duties connected with its position as Recipient (in particular, but not limited to, no Recipient shall be under an obligation to examine the genuineness of the signatures or the authorisation of the signatories). 22.5 For purposes of proof and confirmation only, the Administrative Agent may request that one or several copies of this Agreement shall be originally signed by the Parties. 23. AMENDMENTS Changes to and amendments of this Agreement, including this Clause 23, must be made in writing. 24.
Xxxx Xxxxx and Xx. Xxxxx Xxxx are key technical advisors for Uravan. Uravan is a Calgary Alberta based R&D mineral exploration company specializing in developing new uranium exploration technologies. Our vision is to get to discovery faster and more cost effectively in under-explored frontier areas. Uravan is pursuing exploration for potential high-grade unconformity-related uranium deposits in the Athabasca and Thelon Basins in Canada and other basin environments globally. Uravan is a publicly listed company on the TSX Venture Exchange under the trading symbol UVN. All of the mineral properties Uravan owns are considered in the exploration stage of development. This press release may contain forward looking statements including those describing Uravan’s future plans and the expectations of management that a stated result or condition will occur. Any statement addressing future events or conditions necessarily involves inherent risk and uncertainty. Actual results can differ materially from those anticipated by management at the time of writing due to many factors, the majority of which are beyond the control of Uravan and its management. In particular, this news release contains forward-looking statements pertaining, directly or indirectly, to the following: risks associated with future issuances of Uravan Common Shares, work commitments and the receipt of all required regulatory and other approvals as well as securities and other market conditions and economic factors, business and operations strategies. Readers are cautioned that the foregoing list of risk factors should not be construed as exhaustive. These statements speak only as of the date of this release or as of the date specified in the documents accompanying this release, as the case may be. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements except as expressly required by applicable securities laws.
